Trials / Sponsors / Evergreen Therapeutics, Inc.

Evergreen Therapeutics, Inc.

Industry · 6 registered clinical trials — 4 currently recruiting.

Status	Trial	Phase	Started
Not Yet Recruiting	Efficacy and Safety of a Repurposed Drug Added to the Combination of Len Plus Pem in Advanced Endometrial Canc Advanced Endometrial Cancer	Phase 3	2026-12-01
Not Yet Recruiting	Safety Lead-In Study of a Repurposed Drug Added to the Combination of Len Plus Pem Advanced Endometrial Cancer	Phase 2	2026-08-01
Not Yet Recruiting	Study to Evaluate Safety and Efficacy of EG-301 in Patients With Nonfocal Geographic Atrophy Secondary to Dry- Non-Exudative (Dry) Age-related Macular Degeneration (dAMD)	Phase 2	2026-06-01
Not Yet Recruiting	Pharmacokinetic Study to Evaluate Safety and Tolerability of EG-101 in Healthy Female Volunteers as a Safety L Pre-eclampsia	Phase 1	2026-06-01
Withdrawn	Study to Evaluate the Efficacy and Safety of EG-009A Compared to DEX in Patients With COVID-19 Pneumonia COVID-19 Pneumonia	Phase 2	2022-03-04
Completed	EG-501 for Cognitive Impairment in Neuropsychiatric SLE (NPSLE): Efficacy and Safety Study Neuropsychiatric Systemic Lupus Erythematosus, Systemic Lupus Erythematosus (SLE), Cognitive Impairment	Phase 2	2018-08-23